The genome of Achromobacter xylosoxidansMN001, a strain isolated from sputum derived from an adult cystic fibrosis patient, was sequenced using combined single-molecule real-time and Illumina sequencing. Assembly of the complete genome resulted in a 5,876,039-bp chromosome, representing the smallest A. xylosoxidans genome sequenced to date
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
11Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, ...
The aims of this study were to evaluate the frequency of Achromobacter xylosoxidans infection in a c...
Achromobacter xylosoxidans is an emerging opportunistic pathogen. Here, we present the genome sequen...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
We announce here the complete genome sequence of the Pseudomonas aeruginosamucoid strain FRD1, isola...
We report here the first draft genome sequences of Pseudomonas fluorescens strains that have been is...
The opportunistic human pathogen Achromobacter (Alcaligenes) xylosoxidans has been recovered with in...
Pseudomonas aeruginosa frequently establishes chronic infections in the airways of patients sufferin...
9Achromobacter xylosoxidans is an emerging pathogen increasingly being isolated from respiratory sam...
Achromobacter species are being increasingly isolated from the respiratory tract of cystic fibrosis ...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
Trimethoprim-sulfamethoxazole (SXT) is the preferable treatment option of the infections caused by A...
Pulmonary infections by Gram-negative bacteria such as Achromobacter xylosoxidans are recovered freq...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
11Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, ...
The aims of this study were to evaluate the frequency of Achromobacter xylosoxidans infection in a c...
Achromobacter xylosoxidans is an emerging opportunistic pathogen. Here, we present the genome sequen...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
We announce here the complete genome sequence of the Pseudomonas aeruginosamucoid strain FRD1, isola...
We report here the first draft genome sequences of Pseudomonas fluorescens strains that have been is...
The opportunistic human pathogen Achromobacter (Alcaligenes) xylosoxidans has been recovered with in...
Pseudomonas aeruginosa frequently establishes chronic infections in the airways of patients sufferin...
9Achromobacter xylosoxidans is an emerging pathogen increasingly being isolated from respiratory sam...
Achromobacter species are being increasingly isolated from the respiratory tract of cystic fibrosis ...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
Trimethoprim-sulfamethoxazole (SXT) is the preferable treatment option of the infections caused by A...
Pulmonary infections by Gram-negative bacteria such as Achromobacter xylosoxidans are recovered freq...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
11Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, ...
The aims of this study were to evaluate the frequency of Achromobacter xylosoxidans infection in a c...